173 related articles for article (PubMed ID: 33614226)
1. Angiotensin II-induced muscle atrophy via PPARγ suppression is mediated by miR-29b.
Li J; Yang T; Sha Z; Tang H; Hua X; Wang L; Wang Z; Gao Z; Sluijter JPG; Rowe GC; Das S; Yang L; Xiao J
Mol Ther Nucleic Acids; 2021 Mar; 23():743-756. PubMed ID: 33614226
[TBL] [Abstract][Full Text] [Related]
2. Exercise attenuates angiotensinⅡ-induced muscle atrophy by targeting PPARγ/miR-29b.
Liu Q; Chen L; Liang X; Cao Y; Zhu X; Wang S; Li J; Gao J; Xiao J
J Sport Health Sci; 2022 Nov; 11(6):696-707. PubMed ID: 34116237
[TBL] [Abstract][Full Text] [Related]
3. miR-29b contributes to multiple types of muscle atrophy.
Li J; Chan MC; Yu Y; Bei Y; Chen P; Zhou Q; Cheng L; Chen L; Ziegler O; Rowe GC; Das S; Xiao J
Nat Commun; 2017 May; 8():15201. PubMed ID: 28541289
[TBL] [Abstract][Full Text] [Related]
4. miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-β/Smad3 signaling.
Zhang Y; Huang XR; Wei LH; Chung AC; Yu CM; Lan HY
Mol Ther; 2014 May; 22(5):974-85. PubMed ID: 24569834
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel small-molecule inhibitor of miR-29b attenuates muscle atrophy.
Liu Q; Yuan W; Yan Y; Jin B; You M; Liu T; Gao M; Li J; Gokulnath P; Vulugundam G; Li G; Xu B; Xiao J
Mol Ther Nucleic Acids; 2023 Mar; 31():527-540. PubMed ID: 36891498
[TBL] [Abstract][Full Text] [Related]
6. Delivery of engineered extracellular vesicles with miR-29b editing system for muscle atrophy therapy.
Chen R; Yuan W; Zheng Y; Zhu X; Jin B; Yang T; Yan Y; Xu W; Chen H; Gao J; Li G; Gokulnath P; Vulugundam G; Li J; Xiao J
J Nanobiotechnology; 2022 Jun; 20(1):304. PubMed ID: 35761332
[TBL] [Abstract][Full Text] [Related]
7. rAAV9-mediated supplementation of miR-29b improve angiotensin-II induced renal fibrosis in mice.
Zhang JH; Li J; Ye Y; Yu WQ
Mol Med; 2021 Aug; 27(1):89. PubMed ID: 34407760
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 Mediates Angiotensin II-Induced Liver Fibrosis by Activating NLRP3 Inflammasome/IL-1β Axis via Targeting Smad7 and Spry1.
Ning ZW; Luo XY; Wang GZ; Li Y; Pan MX; Yang RQ; Ling XG; Huang S; Ma XX; Jin SY; Wang D; Li X
Antioxid Redox Signal; 2017 Jul; 27(1):1-20. PubMed ID: 27502441
[TBL] [Abstract][Full Text] [Related]
9. Adipokine CTRP6 improves PPARγ activation to alleviate angiotensin II-induced hypertension and vascular endothelial dysfunction in spontaneously hypertensive rats.
Chi L; Hu X; Zhang W; Bai T; Zhang L; Zeng H; Guo R; Zhang Y; Tian H
Biochem Biophys Res Commun; 2017 Jan; 482(4):727-734. PubMed ID: 27871858
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system.
Kemp JR; Unal H; Desnoyer R; Yue H; Bhatnagar A; Karnik SS
J Mol Cell Cardiol; 2014 Oct; 75():25-39. PubMed ID: 24976017
[TBL] [Abstract][Full Text] [Related]
11. Chronic central miR-29b antagonism alleviates angiotensin II-induced hypertension and vascular endothelial dysfunction.
Sun L; Zhang J; Li Y
Life Sci; 2019 Oct; 235():116862. PubMed ID: 31513814
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of lncRNA MAAT Controls Multiple Types of Muscle Atrophy by cis- and trans-Regulatory Actions.
Li J; Yang T; Tang H; Sha Z; Chen R; Chen L; Yu Y; Rowe GC; Das S; Xiao J
Mol Ther; 2021 Mar; 29(3):1102-1119. PubMed ID: 33279721
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system.
Auclair M; Vigouroux C; Boccara F; Capel E; Vigeral C; Guerci B; Lascols O; Capeau J; Caron-Debarle M
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):829-38. PubMed ID: 23393388
[TBL] [Abstract][Full Text] [Related]
14. Muscle atrophy-related myotube-derived exosomal microRNA in neuronal dysfunction: Targeting both coding and long noncoding RNAs.
Yang CP; Yang WS; Wong YH; Wang KH; Teng YC; Chang MH; Liao KH; Nian FS; Chao CC; Tsai JW; Hwang WL; Lin MW; Tzeng TY; Wang PN; Campbell M; Chen LK; Tsai TF; Chang PC; Kung HJ
Aging Cell; 2020 May; 19(5):e13107. PubMed ID: 32233025
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of circHIPK3 prevents angiotensin II-induced cardiac fibrosis by sponging miR-29b-3p.
Ni H; Li W; Zhuge Y; Xu S; Wang Y; Chen Y; Shen G; Wang F
Int J Cardiol; 2019 Oct; 292():188-196. PubMed ID: 30967276
[TBL] [Abstract][Full Text] [Related]
16. Activation of peroxisome proliferator-activated receptor-γ downregulates soluble epoxide hydrolase in cardiomyocytes.
Pang W; Li N; Ai D; Niu XL; Guan YF; Zhu Y
Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):358-64. PubMed ID: 21291492
[TBL] [Abstract][Full Text] [Related]
17. Protein phosphatase 2C-alpha knockdown reduces angiotensin II-mediated skeletal muscle wasting via restoration of mitochondrial recycling and function.
Tabony AM; Yoshida T; Sukhanov S; Delafontaine P
Skelet Muscle; 2014; 4():20. PubMed ID: 25625009
[TBL] [Abstract][Full Text] [Related]
18. miR-29b regulates Ang II-induced EMT of rat renal tubular epithelial cells via targeting PI3K/AKT signaling pathway.
Hu H; Hu S; Xu S; Gao Y; Zeng F; Shui H
Int J Mol Med; 2018 Jul; 42(1):453-460. PubMed ID: 29568897
[TBL] [Abstract][Full Text] [Related]
19. Role of microRNA-29b in angiotensin II-induced epithelial-mesenchymal transition in renal tubular epithelial cells.
Pan J; Zhang J; Zhang X; Zhou X; Lu S; Huang X; Shao J; Lou G; Yang D; Geng YJ
Int J Mol Med; 2014 Nov; 34(5):1381-7. PubMed ID: 25231273
[TBL] [Abstract][Full Text] [Related]
20. Regulation of podoplanin expression by microRNA-29b associates with its antiapoptotic effect in angiotensin II-induced injury of human podocytes.
Eisenreich A; Langer S; Herlan L; Kreutz R
J Hypertens; 2016 Feb; 34(2):323-31. PubMed ID: 26867059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
